ORPEA Logo

ORPEA

ISIN: FR0000184798 | Ticker: ORP | LEI: 969500LHIH3NT7PK1V89
Sector: Health CareSub-Industry: Health Care Facilities
Country: France

About ORPEA

Company Description

ORPEA is a world leader in global dependency, long-and medium-term physical and psychiatric care

- Long-term care facilities (nursing home)
- Post-acute and rehabilitation clinics
- Psychiatric care clinics
- Home care

Primary objective: the Quality of care

Mission: to care for and support dependent people who have chosen to live in the Group’s facilities, by respecting their comfort, dignity, individuality and autonomy. Continually improving the Quality of care to ensure the wellbeing of residents and patients is at the very heart of ORPEA’s strategy.

Year founded

1989

Served area

Worldwide

Headquarters

12 Rue Jean Jaurès, 92813 PuteauxCedex – France

Financial statements

Download as Excel
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 16,966,502,000.00 18,984,327,000.00 N/A
Noncurrent Assets N/A 14,556,329,000.00 16,181,287,000.00 N/A
Property Plant And Equipment N/A 6,154,741,000.00 7,237,005,000.00 N/A
Goodwill N/A 1,494,270,000.00 1,668,553,000.00 N/A
Intangible Assets Other Than Goodwill N/A 2,881,430,000.00 3,076,406,000.00 N/A
Investments In Subsidiaries Joint Ventures And Associates N/A 187,047,000.00 84,158,000.00 N/A
Deferred Tax Assets N/A 116,111,000.00 115,510,000.00 N/A
Current Trade Receivables N/A 233,223,000.00 431,630,000.00 455,368,000.00
Other Current Receivables N/A 718,290,000.00 1,015,354,000.00 586,957,000.00
Cash and cash equivalents 838,741,000.00 888,836,000.00 952,369,000.00 856,417,000.00
Cash N/A 878,456,000.00 940,782,000.00 597,426,000.00
Cash Equivalents N/A 10,380,000.00 11,586,000.00 258,991,000.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 1,860,173,000.00 2,415,088,000.00 N/A
Noncurrent Assets Or Disposal Groups Classified As Held For Sale N/A 550,000,000.00 387,952,000.00 353,154,000.00
Equity And Liabilities N/A 16,966,502,000.00 18,984,327,000.00 N/A
Equity 3,011,123,000.00 3,489,959,000.00 3,811,228,000.00 N/A
Issued Capital N/A 80,789,000.00 80,800,000.00 N/A
Retained Earnings Profit Loss For Reporting Period N/A N/A 65,185,000.00 -4,027,042,000.00
Equity Attributable To Owners Of Parent N/A 3,495,140,000.00 3,799,448,000.00 N/A
Noncontrolling Interests N/A -5,181,000.00 11,780,000.00 N/A
Noncurrent Liabilities N/A 10,843,153,000.00 11,632,004,000.00 N/A
Noncurrent Provisions N/A 91,713,000.00 148,436,000.00 N/A
Noncurrent Provisions For Employee Benefits N/A 99,243,000.00 75,035,000.00 N/A
Longterm Borrowings N/A 6,037,080,000.00 7,006,775,000.00 1,378,335,000.00
Noncurrent Portion Of Other Noncurrent Borrowings N/A 449,540,000.00 105,000.00 N/A
Current Liabilities N/A 2,633,390,000.00 3,541,095,000.00 N/A
Current Provisions N/A 23,867,000.00 22,464,000.00 N/A
Trade And Other Current Payables To Trade Suppliers N/A N/A 334,797,000.00 326,954,000.00
Current Payables On Social Security And Taxes Other Than Income Tax N/A 310,905,000.00 329,107,000.00 411,874,000.00
Other Current Liabilities N/A N/A 633,297,000.00 529,492,000.00
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A 1,008,159,000.00 1,855,524,000.00 8,236,460,000.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 3,922,392,000.00 4,298,574,000.00 N/A
Employee Benefits Expense 2,210,306,000.00 2,428,888,000.00 N/A
Tax Expense Other Than Income Tax Expense 135,540,000.00 26,373,000.00 63,069,000.00
Profit Loss From Operating Activities 466,992,000.00 354,660,000.00 N/A
Finance Income 16,168,000.00 12,116,000.00 N/A
Finance Costs 272,827,000.00 261,013,000.00 N/A
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method 1,550,000.00 -1,362,000.00 N/A
Profit Loss Before Tax 210,333,000.00 105,763,000.00 N/A
Income Tax Expense Continuing Operations 52,584,000.00 37,539,000.00 N/A
Profit (loss) 159,299,000.00 66,861,000.00 -4,027,579,000.00
Profit Loss Attributable To Owners Of Parent 160,046,000.00 65,185,000.00 N/A
Profit Loss Attributable To Noncontrolling Interests 747,000.00 -1,676,000.00 N/A
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 159,299,000.00 66,861,000.00 -4,027,579,000.00
Adjustments For Decrease Increase In Inventories N/A -7,311,000.00 4,089,000.00 N/A
Adjustments For Decrease Increase In Other Operating Receivables N/A -89,180,000.00 -8,027,000.00 N/A
Adjustments For Increase Decrease In Trade Account Payable N/A 57,133,000.00 25,381,000.00 N/A
Adjustments For Increase Decrease In Other Operating Payables N/A -40,339,000.00 -15,783,000.00 N/A
Other Adjustments For Noncash Items N/A 118,568,000.00 286,732,000.00 N/A
Adjustments For Losses Gains On Disposal Of Noncurrent Assets N/A -19,842,000.00 0.00 N/A
Cash Flows From Used In Operating Activities N/A 777,730,000.00 753,751,000.00 N/A
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 494,439,000.00 421,906,000.00 N/A
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 231,668,000.00 284,125,000.00 N/A
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 750,667,000.00 1,270,736,000.00 N/A
Cash Flows From Used In Investing Activities N/A -1,013,438,000.00 -1,408,517,000.00 N/A
Proceeds From Borrowings Classified As Financing Activities N/A 1,656,958,000.00 2,265,693,000.00 N/A
Repayments Of Borrowings Classified As Financing Activities N/A 933,548,000.00 991,880,000.00 N/A
Cash Flows From Used In Financing Activities N/A 285,803,000.00 718,299,000.00 N/A
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 50,095,000.00 63,533,000.00 -95,952,000.00
Cash and cash equivalents 838,741,000.00 888,836,000.00 952,369,000.00 856,417,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
FRA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
FRA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
30.01.24 None Other Other EUR 13,299,999.99
26.01.24 None Other Other EUR 11,029,750.90
25.01.24 None Other Other EUR 13,286,700.00

Capital markets information

ISIN

FR0000184798

LEI

969500LHIH3NT7PK1V89

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Facilities

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.